CN101884704B - Traditional Chinese medicine for treating asthma - Google Patents
Traditional Chinese medicine for treating asthma Download PDFInfo
- Publication number
- CN101884704B CN101884704B CN2009100842066A CN200910084206A CN101884704B CN 101884704 B CN101884704 B CN 101884704B CN 2009100842066 A CN2009100842066 A CN 2009100842066A CN 200910084206 A CN200910084206 A CN 200910084206A CN 101884704 B CN101884704 B CN 101884704B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- parts
- asthma
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating asthma, and belongs to the field of traditional Chinese medicines for treating respiratory diseases. The traditional Chinese medicine aims to achieve good effect and quick response. The traditional Chinese medicine is prepared from blackberrykiky rhizome, notoginseng root, glossy ganoderma, common coltsfoot flower, Chinese angelica, rehmanniae praeparatum, plantain herb and the like, has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis, relieving sore throat and clearing lung and relieving cough and reducing sputum, and has the advantages of obvious effect, definite curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment respiratory disease.
Background technology
At present, be intended to treat the field of Chinese medicines of asthma, exist the deficiency of several aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Large quantities of asthma patients can not effectively treat and control this disease because of medicine, thus asthma is shown effect repeatedly, touching difficulty more, the patient is sound, unable to lie due to dyspnea in fullness in the chest with rough breath, the larynx usually, and is very painful.Family numbers of patients is very dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of asthma, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of asthma adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Rhizoma Belamcandae 4---25 parts of 25 portions of Radix Notoginseng 3---25 portions of Ganodermas 2---
Flos Farfarae 4---30 parts of 25 parts of Radix Angelicae Sinensis 5---30 parts of Radix Rehmanniae 5---
Herba Plantaginis 4---25 parts
The Chinese medicine of this treatment asthma is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Belamcandae, Flos Farfarae, Radix Angelicae Sinensis, the Radix Rehmanniae, Herba Plantaginis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood in the side; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling; Rhizoma Belamcandae heat-clearing and toxic substances removing, sore-throat relieving lung heat clearing; Flos Farfarae nourishing the lung to keep the adverse QI downward, relieving cough and resolving phlegm; The Herba Plantaginis heat clearing away is eliminated the phlegm, inducing diuresis to remove edema.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, sore-throat relieving lung heat clearing, the merit of relieving cough and resolving phlegm, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Rhizoma Belamcandae 60 gram Radix Notoginseng 50 kairine sesames 40 grams
The Flos Farfarae 60 gram Radix Angelicae Sinensis 80 gram Radix Rehmanniae 80 grams
Herba Plantaginis 60 grams
Weight in accordance with regulations, with conventional water extraction process Rhizoma Belamcandae, Flos Farfarae, Radix Angelicae Sinensis, the Radix Rehmanniae, Herba Plantaginis are extracted, make extractum fine powder 85 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 625 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Rhizoma Belamcandae 180 gram Radix Notoginseng 180 kairine sesames 100 grams
The Flos Farfarae 180 gram Radix Angelicae Sinensis 220 gram Radix Rehmanniae 220 grams
Herba Plantaginis 180 grams
By above-mentioned same method, make 1875 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Rhizoma Belamcandae 250 gram Radix Notoginseng 250 kairine sesames 150 grams
The Flos Farfarae 250 gram Radix Angelicae Sinensis 300 gram Radix Rehmanniae 300 grams
Herba Plantaginis 250 grams
By above-mentioned same method, make 2634 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
5 parts of 7 portions of Ganodermas of 8 portions of Radix Notoginseng of Rhizoma Belamcandae
10 parts in 10 parts of Radix Rehmanniae of 8 parts of Radix Angelicae Sinensis of Flos Farfarae
8 parts of Herba Plantaginiss
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
12 parts of 20 portions of Ganodermas of 22 portions of Radix Notoginseng of Rhizoma Belamcandae
25 parts in 25 parts of Radix Rehmanniae of 18 parts of Radix Angelicae Sinensis of Flos Farfarae
18 parts of Herba Plantaginiss
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science asthma, through 14 routine clinical observations.Selecting tcm diagnosis asthma is standard: patient's limb is soft weak, and is weak on one's body; Usually uncomfortable in chest, pant, cough, dyspnea; Asthma is seasonal outbreak, perhaps cold asthma, perhaps asthma of heat type; Fullness in the chest with rough breath during asthma, the sound pitch breath gushes unable to lie due to dyspnea.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 7 examples, women's 7 examples do not have other serious disease, and the age is 41 years old-82 years old, 62.7 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Uncomfortable in chest, cough, dyspnea are obviously alleviated; The asthma attack number of times reduces, and the time is shorter; Took in 2 months in advance, cold asthma or asthma of heat type outbreak probability reduce.
2, effective: body constitution strengthens, on one's body energetically; Uncomfortable in chest, pant, cough, dyspnea alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.14 philtrums of clinical experiment, produce effects 8 people, effective 5 people, invalid 1 people, total effective rate 93.3%.
Claims (1)
1. a Chinese medicine for the treatment of asthma is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Rhizoma Belamcandae 4---25 parts of 25 portions of Radix Notoginseng 3---25 portions of Ganodermas 2---
Flos Farfarae 4---30 parts of 25 parts of Radix Angelicae Sinensis 5---30 parts of Radix Rehmanniae 5---
Herba Plantaginis 4---25 parts
The Chinese medicine of this treatment asthma is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Belamcandae, Flos Farfarae, Radix Angelicae Sinensis, the Radix Rehmanniae, Herba Plantaginis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100842066A CN101884704B (en) | 2009-05-14 | 2009-05-14 | Traditional Chinese medicine for treating asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100842066A CN101884704B (en) | 2009-05-14 | 2009-05-14 | Traditional Chinese medicine for treating asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101884704A CN101884704A (en) | 2010-11-17 |
| CN101884704B true CN101884704B (en) | 2011-12-21 |
Family
ID=43070904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100842066A Expired - Fee Related CN101884704B (en) | 2009-05-14 | 2009-05-14 | Traditional Chinese medicine for treating asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101884704B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755566B (en) * | 2012-07-18 | 2013-08-28 | 李�杰 | Medicament for treating bronchial asthma |
-
2009
- 2009-05-14 CN CN2009100842066A patent/CN101884704B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101884704A (en) | 2010-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
| CN101884731B (en) | Traditional Chinese medicine for treating silicosis | |
| CN101884704B (en) | Traditional Chinese medicine for treating asthma | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101897847B (en) | Traditional Chinese medicine for curing asthma | |
| CN101850017B (en) | Chinese medicament for treating asthma | |
| CN101850083B (en) | Chinese medicament for treating asthma | |
| CN101843698B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101850018A (en) | Chinese medicament for treating cervical spondylosis | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
| CN101850022B (en) | Anti-infective Chinese medicament | |
| CN101843726B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101850079B (en) | Chinese medicament for treating asthma | |
| CN101850014B (en) | Chinese medicament for treating asthma | |
| CN101843830B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843745B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101850034B (en) | Chinese medicament for treating angina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SUZHOU DANFANG TEXTILE RESEARCH + DEVELOPMENT CO., Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20150104 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 215228 SUZHOU, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150104 Address after: 215228 Jiangsu City, Wujiang Province, Shengze Town, No. two West Ring Road, No. Shengze Textile Science and Technology Park, building 10, 1188 Patentee after: Suzhou Danfang Textile Research & Development Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111221 Termination date: 20190514 |